Literature DB >> 12670344

Increased platelet Fc receptor expression as a potential contributing cause of platelet hypersensitivity to collagen in diabetes mellitus.

David C Calverley1, Michele R Hacker, Kimberly A Loda, Elizabeth Brass, Thomas A Buchanan, Denice D Tsao-Wei, Susan Groshen.   

Abstract

Recent clinical and laboratory observations support a potential role for the platelet FcgammaRIIA receptor (FcR) in collagen-mediated platelet activation associated with arterial thrombosis. Stable age- and sex-independent variation in receptor expression exists. Flow cytometry showed that 100 diabetes patients had increased mean platelet FcR expression levels compared with 201 non-diabetes patients (P < 0.001). Aggregation studies following FcR cross-linking supported a receptor role in increased activation of diabetes platelets after collagen stimulation (P = 0.018). Immunoprecipitation of collagen-stimulated and FcR-crosslinked platelets demonstrated enhanced levels of tyrosine-phosphorylated Syk in diabetic platelets. Increased platelet FcR-mediated sensitivity to collagen may contribute to cardiovascular morbidity and mortality in diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670344     DOI: 10.1046/j.1365-2141.2003.04233.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  16 in total

Review 1.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

Review 2.  Diabetes and antiplatelet therapy: from bench to bedside.

Authors:  Jose R Rivas Rios; Francesco Franchi; Fabiana Rollini; Dominick J Angiolillo
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

3.  Genetic polymorphisms of high platelet reactivity in Chinese patients with coronary heart disease under clopidogrel therapy.

Authors:  Xiao Zou; Xin-Li Deng; Yin-Meng Wang; Jian-Hua Li; Lin Liu; Xin Huang; Lu Liu; Jian Cao; Li Fan
Journal:  Int J Clin Pharm       Date:  2020-04-06

Review 4.  Preventing cardiovascular disease in patients with diabetes: use of aspirin for primary prevention.

Authors:  Dhaval Desai; Haitham M Ahmed; Erin D Michos
Journal:  Curr Cardiol Rep       Date:  2015-03       Impact factor: 2.931

Review 5.  Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence.

Authors:  Mohammed E Al-Sofiani; Robert Derenbecker; Michael Quartuccio; Rita R Kalyani
Journal:  Curr Diab Rep       Date:  2019-09-23       Impact factor: 4.810

6.  Factors contributing to increased platelet reactivity in people with diabetes.

Authors:  David J Schneider
Journal:  Diabetes Care       Date:  2009-04       Impact factor: 17.152

7.  Differential MMP-9 activity in CD34⁺progenitor cell-derived foam cells from diabetic and normoglycemic patients.

Authors:  J U Schmohl; K Daub; S N I von Ungern-Sternberg; S Lindemann; T Schönberger; T Geisler; M Gawaz; P Seizer
Journal:  Herz       Date:  2013-12-05       Impact factor: 1.443

8.  Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.

Authors:  Cunji Gao; Brian Boylan; Dan Bougie; Joan C Gill; Jessica Birenbaum; Debra K Newman; Richard H Aster; Peter J Newman
Journal:  J Clin Invest       Date:  2009-02-09       Impact factor: 14.808

9.  Thrombopoietin Contributes to Enhanced Platelet Activation in Patients with Type 1 Diabetes Mellitus.

Authors:  Ornella Bosco; Barbara Vizio; Gabriella Gruden; Martina Schiavello; Bartolomeo Lorenzati; Paolo Cavallo-Perin; Isabella Russo; Giuseppe Montrucchio; Enrico Lupia
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

10.  Increased platelet expression of FcGammaRIIa and its potential impact on platelet reactivity in patients with end stage renal disease.

Authors:  Feliciano A Serrano; Mohamed El-Shahawy; Richard J Solomon; Burton E Sobel; David J Schneider
Journal:  Thromb J       Date:  2007-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.